The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2013
At a glance
- Drugs Ambrisentan (Primary) ; Aminophylline (Primary)
- Indications Asthma; Bronchitis
- Focus Adverse reactions; Pharmacokinetics
- 05 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 13 Feb 2012 New trial record